- Home
- AMRN vs NPCT Comparison
AMRN vs NPCT Comparison
Compare AMRN & NPCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMRN
- NPCT
- Stock Information
- Founded
- AMRN 1989
- NPCT 2020
- Country
- AMRN Ireland
- NPCT United States
- Employees
- AMRN N/A
- NPCT N/A
- Industry
- AMRN Biotechnology: Pharmaceutical Preparations
- NPCT Investment Managers
- Sector
- AMRN Health Care
- NPCT Finance
- Exchange
- AMRN Nasdaq
- NPCT Nasdaq
- Market Cap
- AMRN 302.0M
- NPCT 306.8M
- IPO Year
- AMRN 1993
- NPCT N/A
- Fundamental
- Price
- AMRN $19.18
- NPCT $10.72
- Analyst Decision
- AMRN Strong Sell
- NPCT
- Analyst Count
- AMRN 1
- NPCT 0
- Target Price
- AMRN $12.00
- NPCT N/A
- AVG Volume (30 Days)
- AMRN 144.3K
- NPCT 107.1K
- Earning Date
- AMRN 10-29-2025
- NPCT 01-01-0001
- Dividend Yield
- AMRN N/A
- NPCT 9.82%
- EPS Growth
- AMRN N/A
- NPCT N/A
- EPS
- AMRN N/A
- NPCT N/A
- Revenue
- AMRN $219,361,000.00
- NPCT N/A
- Revenue This Year
- AMRN N/A
- NPCT N/A
- Revenue Next Year
- AMRN N/A
- NPCT N/A
- P/E Ratio
- AMRN N/A
- NPCT N/A
- Revenue Growth
- AMRN N/A
- NPCT N/A
- 52 Week Low
- AMRN $7.08
- NPCT $8.58
- 52 Week High
- AMRN $20.90
- NPCT $10.63
- Technical
- Relative Strength Index (RSI)
- AMRN 58.42
- NPCT 42.79
- Support Level
- AMRN $19.02
- NPCT $10.60
- Resistance Level
- AMRN $20.90
- NPCT $11.00
- Average True Range (ATR)
- AMRN 0.93
- NPCT 0.10
- MACD
- AMRN -0.15
- NPCT -0.01
- Stochastic Oscillator
- AMRN 40.81
- NPCT 29.69
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.
About NPCT Nuveen Core Plus Impact Fund of Beneficial Interest
Nuveen Core Plus Impact Fund is an organized, diversified, closed-end management investment company. The Fund's investment objective is to seek total return through high current income and capital appreciation, while giving special consideration to certain impact and environmental, social and governance criteria.